Search results
Here’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)
Insider Monkey via Yahoo Finance· 5 hours agoWe recently published the list of 11 stocks Jim Cramer is bearish on. Bristol-Myers Squibb Co...
Rockville’s I-Mab, Bristol Myers Squibb to collaborate on new cancer study - Maryland Daily Record
The Daily Record· 42 minutes agoUnder the terms of the agreement, the study will be a multi-national Phase 1 study conducted by I-Mab. Bristol Myers Squibb will supply nivolumab. Nivolumab is an immune checkpoint inhibitor ...
BMS’ Opdivo-Yervoy treatment improves survival in hepatocellular carcinoma trial
Clinical Trials Arena via Yahoo Finance· 8 hours agoBristol Myers Squibb (BMS) has announced findings from the Phase III CheckMate -9DW trial where...
Bristol Myers Squibb Announces Phase 3 Results Of Opdivo/Yervoy Combo In Liver Cancer Patients -...
Benzinga· 1 day agoOpdivo plus Yervoy combo shows significant survival benefits and higher response rates vs....
Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested a year ago
Simply Wall St. via Yahoo Finance· 1 day agoThe simplest way to benefit from a rising market is to buy an index fund. But if you buy individual...
Bristol Myers Squibb’s Breyanzi shows promise in B-cell malignancy clinical trials
Clinical Trials Arena via Yahoo Finance· 1 day agoUS-based pharmaceutical company Bristol Myers Squibb (BMS) has published data from three studies in...
Why US Drug Giant Bristol Myers Squibb Stock Trading Up On Monday - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 2 days agoBristol Myers Squibb & Co BMY announced on Saturday (June 1) results from the Phase 3 KRYSTAL-12...
Rathbones Group PLC Trims Stock Position in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 1 day agoRathbones Group PLC reduced its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 24.0% in the 4th quarter, according to its most recent 13F filing with the Securities and ...
Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Today
Zacks via Yahoo Finance· 2 days agoThe latest trading session saw Bristol Myers Squibb (BMY) ending at $41.77, denoting a +1.65%...
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 6 days agoBristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it...